LifeMD, Inc. (LFMD)

NASDAQ: LFMD · IEX Real-Time Price · USD
2.04
+0.06 (3.03%)
Feb 1, 2023, 10:09 AM EST - Market open
3.03%
Market Cap 64.16M
Revenue (ttm) 118.33M
Net Income (ttm) -54.91M
Shares Out 31.45M
EPS (ttm) -1.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,306
Open 1.98
Previous Close 1.98
Day's Range 1.97 - 2.04
52-Week Range 1.72 - 4.32
Beta 1.35
Analysts Buy
Price Target 8.16 (+300.0%)
Earnings Date Mar 6, 2023

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair lo... [Read more]

Sector Healthcare
Founded 1994
Employees 196
Stock Exchange NASDAQ
Ticker Symbol LFMD
Full Company Profile

Financial Performance

In 2021, LifeMD's revenue was $92.88 million, an increase of 149.04% compared to the previous year's $37.29 million. Losses were -$61.77 million, -2.52% less than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for LFMD stock is "Buy." The 12-month stock price forecast is $8.16, which is an increase of 300.00% from the latest price.

Price Target
$8.16
(300.00% upside)
Analyst Consensus: Buy
Stock Forecasts

News

LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company's Rapid Expansion into Virtual Primary Care

NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Jessica Friedeman as Chief Marketing Officer...

1 month ago - GlobeNewsWire

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Dec. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividen...

1 month ago - GlobeNewsWire

LifeMD, Inc. to Participate in Upcoming Investor Conferences

NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the following upcomi...

2 months ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 88.89% and 2.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

LifeMD, Inc. Reports Third Quarter 2022 Results

NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the third quarter ended September 30, 2022. All figure com...

2 months ago - GlobeNewsWire

LifeMD and Cleared Offer New Hope to Allergy Patients Through Strategic Partnership With Allergenis

Strategic partnership enables direct-to-consumer food allergy clinic to provide convenient access to crucial peanut allergy threshold information Strategic partnership enables direct-to-consumer food ...

5 months ago - GlobeNewsWire

LifeMD, Inc. Reports Second Quarter 2022 Results

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the second quarter ended June 30, 2022. All figure compari...

6 months ago - GlobeNewsWire

LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the secon...

6 months ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Upgraded to Buy: Here's Why

LifeMD, Inc. (LFMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

7 months ago - Zacks Investment Research

LifeMD, Inc. (LFMD) Reports Q1 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 3.85% and 6.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

LifeMD, Inc. Reports First Quarter 2022 Results

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the first quarter ended March 31, 2022. All figure comparis...

9 months ago - GlobeNewsWire

LifeMD to Participate in the Upcoming May Conferences

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that that management will participate in the following upcomin...

9 months ago - GlobeNewsWire

LifeMD to Participate in the 21st Annual Needham Virtual Healthcare Conference

NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that that management will participate in the 21st Annual Needh...

10 months ago - GlobeNewsWire

LifeMD Launches Proprietary Over-the-Counter Skincare Line for Women, Expanding Teledermatology Offerings

NavaMD's clinically studied, OTC skincare platform is protected by a global intellectual property portfolio and $50+ Million of third-party capital invested in R&D, clinical research, and manufacturin...

11 months ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Reports Q4 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 25.64% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

LifeMD Reports Fourth Quarter and Full Year 2021 Results

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the fourth quarter and year ended December 31, 2021. All ...

11 months ago - GlobeNewsWire

LifeMD to Host 2022 Virtual Analyst and Investor Day

Presentations to Highlight Primary Care Technology Platform, Recently Acquired Allergy, Asthma & Immunology Business, and Details on 2022 Revenue Mix and Growth Strategy Presentations to Highlight Pri...

1 year ago - GlobeNewsWire

LifeMD to Participate in the Upcoming February Investor Conferences

NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the SVB Lee...

1 year ago - GlobeNewsWire

3 Medical Services Stocks to Buy Despite Near-Term Industry Woes

The Zacks Medical - Services industry is growing on digital healthcare adoption. AMN, AMEH and LFMD are set to gain the most.

Other symbols: AMEHAMN
1 year ago - Zacks Investment Research

LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform

Acquisition of Cleared Further Diversifies LifeMD's Telehealth Offerings to Encompass  Allergy, Asthma, and Immunology

1 year ago - GlobeNewsWire

LifeMD to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022

CEO Schreiber to discuss changes made possible via proprietary virtual care platforms CEO Schreiber to discuss changes made possible via proprietary virtual care platforms

1 year ago - GlobeNewsWire

LifeMD to Participate in Upcoming January Investor Conferences

NEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the followi...

1 year ago - GlobeNewsWire

LifeMD to Participate in the Stephens Annual Investment Conference

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) --   LifeMD, Inc.  (“the Company”) (NASDAQ: LFMD) today announced that management will present at the Stephens Annual Investment Conference on Monday, November...

1 year ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Reports Q3 Loss, Tops Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 26.53% and 1.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

LifeMD to Release Third Quarter 2021 Financial Results on Wednesday, November 10, 2021

Hosted conference call to begin at 5:00 p.m. ET Hosted conference call to begin at 5:00 p.m. ET

1 year ago - GlobeNewsWire